These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
485 related articles for article (PubMed ID: 35847516)
41. Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer's Disease. Muraleedharan A; Ray SK Brain Sci; 2024 Jan; 14(1):. PubMed ID: 38275516 [TBL] [Abstract][Full Text] [Related]
42. Pharmacological modulation of autophagy for epilepsy therapy: Opportunities and obstacles. Chen W; Zhang J; Zhang Y; Zhang J; Li W; Sha L; Xia Y; Chen L Drug Discov Today; 2023 Jun; 28(6):103600. PubMed ID: 37119963 [TBL] [Abstract][Full Text] [Related]
43. The role of Li Q; Wang BL; Sun FR; Li JQ; Cao XP; Tan L Ann Transl Med; 2018 May; 6(10):178. PubMed ID: 29951500 [TBL] [Abstract][Full Text] [Related]
44. The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer's disease. Liu X; Ye M; Ma L Front Aging Neurosci; 2022; 14():1022821. PubMed ID: 36325189 [TBL] [Abstract][Full Text] [Related]
45. Multidimensional autophagy nano-regulator boosts Alzheimer's disease treatment by improving both extra/intraneuronal homeostasis. Li Y; Yang P; Meng R; Xu S; Zhou L; Qian K; Wang P; Cheng Y; Sheng D; Xu M; Wang T; Wu J; Cao J; Zhang Q Acta Pharm Sin B; 2024 Mar; 14(3):1380-1399. PubMed ID: 38486986 [TBL] [Abstract][Full Text] [Related]
46. Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease. Uddin MS; Kabir MT; Mamun AA; Barreto GE; Rashid M; Perveen A; Ashraf GM Int Immunopharmacol; 2020 Jul; 84():106479. PubMed ID: 32353686 [TBL] [Abstract][Full Text] [Related]
47. Alzheimer's disease-related misfolded proteins and dysfunctional organelles on autophagy menu. Correia SC; Resende R; Moreira PI; Pereira CM DNA Cell Biol; 2015 Apr; 34(4):261-73. PubMed ID: 25664381 [TBL] [Abstract][Full Text] [Related]
48. Toll-like receptors in Alzheimer's disease: a therapeutic perspective. Gambuzza ME; Sofo V; Salmeri FM; Soraci L; Marino S; Bramanti P CNS Neurol Disord Drug Targets; 2014; 13(9):1542-58. PubMed ID: 25106635 [TBL] [Abstract][Full Text] [Related]
49. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model. Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967 [TBL] [Abstract][Full Text] [Related]
50. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases. Wu AG; Zhou XG; Qiao G; Yu L; Tang Y; Yan L; Qiu WQ; Pan R; Yu CL; Law BY; Qin DL; Wu JM Ageing Res Rev; 2021 Jan; 65():101202. PubMed ID: 33161129 [TBL] [Abstract][Full Text] [Related]
51. Dihydroartemisinin Ameliorates Learning and Memory in Alzheimer's Disease Through Promoting Autophagosome-Lysosome Fusion and Autolysosomal Degradation for Aβ Clearance. Zhao Y; Long Z; Ding Y; Jiang T; Liu J; Li Y; Liu Y; Peng X; Wang K; Feng M; He G Front Aging Neurosci; 2020; 12():47. PubMed ID: 32210783 [TBL] [Abstract][Full Text] [Related]
52. Activate or Inhibit? Implications of Autophagy Modulation as a Therapeutic Strategy for Alzheimer's Disease. Krishnan S; Shrestha Y; Jayatunga DPW; Rea S; Martins R; Bharadwaj P Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937909 [TBL] [Abstract][Full Text] [Related]
55. Selenium-enriched yeast inhibited β-amyloid production and modulated autophagy in a triple transgenic mouse model of Alzheimer's disease. Song GL; Chen C; Wu QY; Zhang ZH; Zheng R; Chen Y; Jia SZ; Ni JZ Metallomics; 2018 Aug; 10(8):1107-1115. PubMed ID: 30043821 [TBL] [Abstract][Full Text] [Related]
56. Early etiology of Alzheimer's disease: tipping the balance toward autophagy or endosomal dysfunction? Peric A; Annaert W Acta Neuropathol; 2015 Mar; 129(3):363-81. PubMed ID: 25556159 [TBL] [Abstract][Full Text] [Related]
57. Role of Neuron and Glia in Alzheimer's Disease and Associated Vascular Dysfunction. Bandyopadhyay S Front Aging Neurosci; 2021; 13():653334. PubMed ID: 34211387 [TBL] [Abstract][Full Text] [Related]
58. Compromised autophagy and mitophagy in brain ageing and Alzheimer's diseases. Caponio D; Veverová K; Zhang SQ; Shi L; Wong G; Vyhnalek M; Fang EF Aging Brain; 2022; 2():100056. PubMed ID: 36908880 [TBL] [Abstract][Full Text] [Related]
59. Autophagy and Alzheimer's Disease. Li Q; Liu Y; Sun M Cell Mol Neurobiol; 2017 Apr; 37(3):377-388. PubMed ID: 27260250 [TBL] [Abstract][Full Text] [Related]
60. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models. Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]